{"organizations": [], "uuid": "2fd30e66bdd368c9a1c9c53cd6dfeff355a73fdc", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180420.html", "section_title": "Archive News &amp; Video for Friday, 20 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-strides-shasun-says-nclt-approves/brief-strides-shasun-says-nclt-approves-cos-scheme-of-arrangement-with-sequent-scientific-and-solara-active-pharma-sciences-idUSFWN1RX08T", "country": "US", "domain_rank": 408, "title": "BRIEF-Strides Shasun Says NCLT Approves Co's Scheme Of Arrangement With Sequent Scientific And Solara Active Pharma Sciences", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.048, "site_type": "news", "published": "2018-04-20T15:38:00.000+03:00", "replies_count": 0, "uuid": "2fd30e66bdd368c9a1c9c53cd6dfeff355a73fdc"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-strides-shasun-says-nclt-approves/brief-strides-shasun-says-nclt-approves-cos-scheme-of-arrangement-with-sequent-scientific-and-solara-active-pharma-sciences-idUSFWN1RX08T", "ord_in_thread": 0, "title": "BRIEF-Strides Shasun Says NCLT Approves Co's Scheme Of Arrangement With Sequent Scientific And Solara Active Pharma Sciences", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "sequent scientific and solara active pharma sciences", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "brief-strides shasun says nclt approves co", "sentiment": "negative"}, {"name": "strides shasun ltd", "sentiment": "negative"}, {"name": "sequent", "sentiment": "none"}, {"name": "n co", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 20 (Reuters) - Strides Shasun Ltd:\n* SAYS NCLT APPROVED COMPOSITE SCHEME OF ARRANGEMENT BETWEEN CO, SEQUENT SCIENTIFIC AND SOLARA ACTIVE PHARMA SCIENCES Source text - bit.ly/2HLmsbG Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/", "http://bit.ly/2HLmsbG"], "published": "2018-04-20T15:38:00.000+03:00", "crawled": "2018-04-21T18:15:06.025+03:00", "highlightTitle": ""}